Analysis of targeted sequencing of ERBB2 in multiple disease and control cohorts revealed that rare germline ERBB2 coding variants are more frequently associated with MPN compared to other hematologic malignancies as well as non-cancer controls. This evidence concerns the gene ERBB2 and cancer.